-
, and processing conditions influence their behaviour, creating a vast and complex landscape that traditional experimentation cannot navigate efficiently. This project addresses this challenge by bringing
-
regions (UL-CDRs) represent a unique structural class with exceptional potential for targeting otherwise inaccessible epitopes. These UL-CDRs feature a distinctive architecture comprising a β-ribbon stalk
-
prevalent noncommunicable disease globally. The confined and complex architecture of the oral cavity, particularly in regions such as dentinal tubules and root canals, makes effective antimicrobial treatment
-
disinfectants. With antimicrobial resistance (AMR) on the rise, there is an urgent need for non-antibiotic strategies to prevent and control biofilm formation on medical devices. This PhD project proposes a novel
-
rather than the structured biofilms found in real-world environments. This project investigates how engineered surface topographies influence HGT dynamics, aiming to develop design principles for materials
-
PhD Studentship: Nanopore Technology for Rapid and Accurate Measurement of Antibiotic Concentrations
the environment and the lack of routine monitoring tools. Current methods for measuring antibiotic concentrations, such as HPLC and mass spectrometry, are expensive and require complex instrumentation, limiting
-
, and biotechnology. Research Environment: The project is a collaboration between UCL Chemistry, Pharmacy, and Chemical Engineering departments. Students will work across multiple labs, benefiting from a
-
healthcare settings. Approach and Methods: Synthesize gold nanostars with optimised optical and surface properties for enhanced plasmonic signal amplification Engineer LFA architectures incorporating salt
-
refer to the following website for eligibility criteria: https://www.ucl.ac.uk/prospective-students/graduate/research-degrees/physics-and-astronomy-mphil-phd . The studentship will cover university fees
-
across clinical and physical sciences Research Environment Hoogenboom Lab: Pioneers in AFM imaging of bacteria, supported by BBSRC and Wellcome. Brown Lab: Leader in pneumonia pathogenesis, equipped